Search results for "kings college london"
Selected Filters:
Trends and technologies in pharmaceutical manufacturing
Aptamer Group introduces novel biomarker discovery service
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
Collaboration leverages advanced simulation and regulatory expertise to develop decision frameworks for interim overall survival analysis in oncology clinical trials
Bio-Rad expands range of StarBright Dyes to enhance panel design capabilities for spectral flow cytometry
New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
Qureight’s 3D AI imaging platform to support Calluna Pharma’s Phase 2 IPF Trial of CAL101 in idiopathic pulmonary fibrosis
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
How CancerTools.org is making cancer research faster, more accessible and collaborative
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
Detection strategies for PFAS and emerging water contaminants
TARGATT large knock-in technology
Addressing the analytical gaps in modern therapeutic development
How to tackle PFAS in the shifting regulatory landscape
PFAS analysis without compromise
Hypertension as a driver of cardiovascular and renal disease
Fast, slide-free cell counting with CellDrop
AliveDx’s MosaiQ gains FDA Class II 510(k) exempt device status
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
How to Buy Analytical Technology for Cell Line Development
As cell line development programs for biopharmaceutical development grow in complexity and scale, with increasing demands for speed, data quality, and adaptability, it is essential to choose the right analytical technology and tools that will future proof your workflow.
Trailblazing earlier diagnosis of multiple myeloma for better patient outcomes
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific
























